Login
$GSK
$50.25 -$0.16 (0.32%) After hours

Ownership

13F as of Q2 2026 · 4.32B shares outstanding

Who owns GSK?

By type of holder
Institutions 8.1% Everyone else 91.9%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 5.2%
FMR LLC 1.5% · Dodge & Cox 1.1%
Institutional ownership
8.1%
-0.7 pts vs last qtr
Institutional holders
1,033
-2 vs last qtr
Net shares bought
−28.2M
by institutions in Q2 2026
New / sold out
107 / 109
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Point72 Asset Management, L.P. NEW +2.7M
  • Jpmorgan Chase & Co +1.5M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Dodge & Cox −10.5M
  • Holocene Advisors, LP SOLD OUT −5.5M

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$2.31M
1 notice from 1 person
Shares covered
44.4K
0.00% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$1.2M$2.3MDecJanFebMarAprMayJunJulAug 2026: $2.3M without a planAugSepOctNov
Largest proposed sellers
  • Martinez Maria E Officer $2.31M
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2025
−16.7%
−2.25% a year
Each share's claim on the business
+20.0%
grew without buying or selling a share
Spent on buybacks vs paid in stock
— vs GBP 3.11B
over 9 fiscal years
Diluted shares, split-adjusted
3.91B4.49B5.07B2017: 4.94B shares'172018: 4.97B shares'182019: 5.02B shares'192020: 4.03B shares'202021: 4.05B shares'212022: 4.08B shares'222023: 4.11B shares'232024: 4.14B shares'242025: 4.12B shares'25
Buybacks Stock-based comp
GBP 0GBP 187.0MGBP 374.0M2017 buybacks: GBP 02017 stock comp: GBP 333.0M'172018 buybacks: GBP 02018 stock comp: GBP 360.0M'182019 buybacks: GBP 02019 stock comp: GBP 365.0M'192020 buybacks: GBP 02020 stock comp: GBP 337.0M'202021 buybacks: GBP 02021 stock comp: GBP 343.0M'212022 buybacks: GBP 02022 stock comp: GBP 346.0M'222023 buybacks: GBP 02023 stock comp: GBP 307.0M'232024 buybacks: GBP 02024 stock comp: GBP 344.0M'242025 buybacks: GBP 02025 stock comp: GBP 374.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years89% 1–3 years5% Under 1 year6%
Quarterly turnover
8.2%
of institutional shares changed hands
Top 10 managers, median time held
3.8 years

Super Investors

Investment managers reporting GSK on Form 13F
F
FMR LLC
Shares
65.0M
% of company
1.51%
Change vs last qtr
−2.7M (−4.0%)
Held since
2022
DC
Dodge & Cox
Shares
48.2M
% of company
1.12%
Change vs last qtr
−10.5M (−17.8%)
Held since
2022

28 more super investors behind a free account

See every manager holding GSK plc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting GSK on Form N-PORT; together they hold 4.7% of the company
DC
Dodge & Cox Funds
Position value
$1.86B
% of company
0.82%
% of the fund
1.58%
As of
June 30, 2026
Position value
$1.66B
% of company
1.47%
% of the fund
2.46%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding GSK plc and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support